The Hospital of Central Connecticut, part of Hartford (Conn.) Healthcare, has filed an application with the state seeking permission to relocate its medical oncology service in a move it said will better accommodate expansions, the Hartford Business Journal reported June…
The Latest
Orlando, Fla.-based AdventHealth Cancer Institute launched a first-of-its-kind bladder cancer vaccine trial that will use patient-customized mRNA vaccines.
Chapel Hill, N.C.-based Lineberger Comprehensive Cancer Center, part of the University of North Carolina, has tapped Robert Ferris, MD, PhD, to become its next executive director, it announced June 19.
Nathan Berger, MD, University Hospitals Seidman Cancer Center's former chief of the hematology and oncology division, died June 16.
Like many small hospitals, Doylestown (Pa.) Health provides cancer care but often sees patients going to larger centers such as Fox Chase Cancer Center or Penn Medicine, both based in Philadelphia. This has led Sean Reinhardt, MD, chief medical officer…
Pfizer anticipates developing eight or more potential "blockbuster" cancer drugs by 2030.
Kentucky has the highest cancer incidence rate, while Nevada has the lowest, a USAFacts report found.
A National Cancer Institute study found that members of Generation X may be experiencing larger per-capita increases in the incidence of cancer compared to any prior generation.
Fox Chase Cancer Center in Philadelphia has been given $10.8 million to further pancreatic cancer research, it announced June 12.
New York City-based NYU Langone Health's Perlmutter Cancer Center and the University of Glasgow in Scotland developed an artificial intelligence-powered tool that was 99% accurate in distinguishing between two lung cancers.